Erosion of Transplantation Tolerance After Infection

American Journal of Transplantation

Volumn 17, Issue 1, 2017, Pages 81-90

  Young, J S ^a   Daniels, M D ^a,b   Miller, M L ^a   Wang, T ^a,c   Zhong, R ^a   Yin, D ^a   Alegre, M L ^a   Chong, A S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CHICAGO STATE UNIVERSITY   (United States)

^c First Hospital of Yunnan Province   (China)

Author keywords

animal models: murine; bacterial; basic (laboratory) research science; immunosuppression immune modulation; infection and infectious agents; tolerance: costimulation blockade; tolerance: experimental

Indexed keywords

BRUTON TYROSINE KINASE; CD134 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD79B ANTIGEN; CD81 ANTIGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; EOTAXIN 2; FAS ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 7 RECEPTOR; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLK GENE; CARDIAC GRAFT REJECTION; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GRAFT SURVIVAL; HEART TRANSPLANTATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MAP3K6 GENE; MAPK81P3 GENE; MOUSE; NONHUMAN; PALPATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKAP1 GENE; ST6GAL1 GENE; TRANSPLANTATION TOLERANCE; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; GRAFT REJECTION; IMMUNOLOGY; VIROLOGY;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84978864617     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13910     Document Type: Article

References (47)

1. Kawai T, Leventhal J, Madsen JC, Strober S, Turka LA, Wood KJ. Tolerance: one transplant for life. Transplantation 2014; 98: 117–121.
2. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353–361.
3. Leventhal J, Levitsky J, Abecassis MM, et al. Spontaneous operational tolerance in kidney transplant recipients. Am J Transplant 2012; 12: 1350; author reply 1351–1352.
4. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836–1847.
5. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848–1861.
6. Brouard S, Pallier A, Renaudin K, et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 2012; 12: 3296–3307.
7. Kawai T, Sachs DH, Sprangers B, et al. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant 2014; 14: 1599–1611.
8. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887–1895.
9. Brehm MA, Markees TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003; 170: 4077–4086.
10. Chen L, Ahmed E, Wang T, et al. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol 2009; 182: 6217–6225.
11. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282–2291.
12. Ahmed EB, Wang T, Daniels M, Alegre ML, Chong AS. IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice. Am J Transplant 2011; 11: 936–946.
13. Wang T, Chen L, Ahmed E, et al. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol 2008; 180: 5991–5999.
14. Burns AM, Chong AS. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol 2011; 186: 214–221.
15. Burns AM, Ma L, Li Y, et al. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol 2009; 182: 1314–1324.
16. Wang T, Ahmed EB, Chen L, et al. Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant 2010; 10: 1524–1533.
17. Miller ML, Daniels MD, Wang T, et al. Spontaneous restoration of transplantation tolerance after acute rejection. Nat Commun 2015; 6: 7566.
18. Schietinger A, Delrow JJ, Basom RS, Blattman JN, Greenberg PD. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science 2012; 335: 723–727.
19. Miller ML, Daniels MD, Wang TM, et al. Tracking of TCR-Tg T cells reveals multiple mechanisms maintain cardiac transplant tolerance in mice. Am J Transplant 2016; doi: 10.1111/ajt.13814 [Epub ahead of print].
20. Egawa H, Miyagawa-Hayashino A, Haga H, et al. Non inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res 2012; 42: 895–903.
21. Yoshitomi M, Koshiba T, Haga H, et al. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009; 87: 606–614.
22. Tryphonopoulos P, Ruiz P, Weppler D, et al. Long-term follow-up of 23 operational tolerant liver transplant recipients. Transplantation 2010; 90: 1556–1561.
23. Feng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012; 307: 283–293.
24. de Vries VC, Pino-Lagos K, Elgueta R, Noelle RJ. The enigmatic role of mast cells in dominant tolerance. Curr Opin Organ Transplant 2009; 14: 332–337.
25. de Vries VC, Pino-Lagos K, Nowak EC, Bennett KA, Oliva C, Noelle RJ. Mast cells condition dendritic cells to mediate allograft tolerance. Immunity 2011; 35: 550–561.
26. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442: 997–1002.
27. Wasiuk A, Dalton DK, Schpero WL, Stan RV, Conejo-Garcia JR, Noelle RJ. Mast cells impair the development of protective anti-tumor immunity. Cancer Immunol Immunother 2012; 61: 2273–2282.
28. Xiao X, Gong W, Demirci G, et al. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol 2012; 188: 892–901.
29. Kinnear G, Wood KJ, Fallah-Arani F, Jones ND. A diametric role for OX40 in the response of effector/memory CD4 + T cells and regulatory T cells to alloantigen. J Immunol 2013; 191: 1465–1475.
30. Chesneau M, Pallier A, Braza F, et al. Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant 2014; 14: 144–155.
31. Zheng Y, Zha Y, Gajewski TF. Molecular regulation of T-cell anergy. EMBO Rep 2008; 9: 50–55.
32. Janardhan SV, Praveen K, Marks R, Gajewski TF. Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4 + T cells. PLoS One 2011; 6: e24931.
33. Adler HS, Kubsch S, Graulich E, Ludwig S, Knop J, Steinbrink K. Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood 2007; 109: 4351–4359.
34. Eun SY, Lee SW, Xu Y, Croft M. 4-1BB ligand signaling to T cells limits T cell activation. J Immunol 2015; 194: 134–141.
35. Turner JE, Paust HJ, Steinmetz OM, et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 2010; 21: 974–985.
36. Villares R, Cadenas V, Lozano M, et al. CCR6 regulates EAE pathogenesis by controlling regulatory CD4 + T-cell recruitment to target tissues. Eur J Immunol 2009; 39: 1671–1681.
37. Zhang R, Borges CM, Fan MY, Harris JE, Turka LA. Requirement for CD28 in effector regulatory T cell differentiation, CCR6 induction, and skin homing. J Immunol 2015; 195: 4154–4161.
38. Mamonkin M, Shen Y, Lee PH, Puppi M, Park CS, Lacorazza HD. Differential roles of KLF4 in the development and differentiation of CD8 + T cells. Immunol Lett 2013; 156: 94–101.
39. Baliu-Pique M, Jusek G, Holzmann B. Neuroimmunological communication via CGRP promotes the development of a regulatory phenotype in TLR4-stimulated macrophages. Eur J Immunol 2014; 44: 3708–3716.
40. Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. Coinhibitory pathways in immunotherapy for cancer. Annu Rev Immunol 2016; 34: 539–573.
41. Ito T, Ueno T, Clarkson MR, et al. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol 2005; 174: 6648–6656.
42. Tanaka K, Albin MJ, Yuan X, et al. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol 2007; 179: 5204–5210.
43. Yang J, Popoola J, Khandwala S, et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 2008; 117: 660–669.
44. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007; 27: 111–122.
45. Francisco LM, Salinas VH, Brown KE, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206: 3015–3029.
46. Yamada Y, Nadazdin O, Boskovic S, et al. Repeated injections of IL-2 break renal allograft tolerance induced via mixed hematopoietic chimerism in monkeys. Am J Transplant 2015; 15: 3055–3066.
47. Scalea JR, Okumi M, Villani V, et al. Abrogation of renal allograft tolerance in MGH miniature swine: the role of intra-graft and peripheral factors in long-term tolerance. Am J Transplant 2014; 14: 2001–2010.